MSCT efficacy in the treatment of fatty liver of the quantitative role.docVIP

 PAGE \* MERGEFORMAT 11 MSCT efficacy in the treatment of fatty liver of the quantitative role [Abstract] Objective To study the preliminary study (Multi-slice Spiral Computed tomography MSCT) of helical CT scan in the treatment of fatty liver observed in the quantitative effect. Methods 38 patients with fatty liver glutathione United Arab people Salvia treatment, observation and treatment CT attenuation values #8203;#8203;before and after the liver and spleen CT attenuation values, changes in liver function and blood lipids. Results After treatment, the liver fatty liver CT attenuation values #8203;#8203;increased an average of 10 +-5Hu, and the spleen no significant changes in CT attenuation values, treatment After the liver function, blood lipids decreased significantly, the data before and after treatment with a significant difference between groups (p lt;0.05). Conclusion The observation of fatty liver therapy, the use of CT attenuation values #8203;#8203;observed over the liver lipids, liver function closer to the pathological changes in the liver itself However, using CT attenuation values #8203;#8203;of liver fatty liver observed in this indicator is still in the therapeutic effect of a preliminary study, it is worth further study. [Key Words] multi-slice spiral computed tomography liver lipid A glutathione [Abstract] Objective To study the role of MSCT scaning in observing the efficacy of treating fatty liver with Reduced Glutathione and Danshen Root. Methods 38 patients with fatty liver disease were treated with Reduced Glutathione and Danshen Root for 4 weeks, before and after treatment liver function, serum lipid and imaging changes were observed. Results Serum SGTP, TG, TC were reduced remarkble after treatment, attenuation of liver have raised after treatment, the value of meaning was 10 +-5Hu and it has statistical distinct difference. Conclusion Reduced Glutathione and Danshen Root have favorable results in treanting fatty liver disease